Skip to content

Impact of Asthma Treatments on Daily Activities

Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00350376
Enrollment
1500
Registered
2006-07-10
Start date
2006-06-30
Completion date
Unknown
Last updated
2006-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergies, Asthma

Keywords

asthma, allergies, Xolair, Advair

Brief summary

The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.

Interventions

None listed

Sponsors

Genentech, Inc.
CollaboratorINDUSTRY
Ovation Research Group
Lead SponsorINDUSTRY

Study design

Observational model
DEFINED_POPULATION
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years

Inclusion criteria

* Have asthma and allergies * Currently taking Xolair® or Advair® * Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair® for at least 12 months * Between 18 and 55 years of age * A non-smoker for at least 6 months * Have internet access

Countries

United States

Contacts

Primary ContactNita Ngo, MPH
asthmastudy@ovation.org888.631.9167

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026